Publications by authors named "Perry M. Elliott"

Claim this Profile
T
The p.Asn271Ile Variant in the TNNT2 Gene Is Associated With Low-Risk Late-Onset Hypertrophic Cardiomyopathy.
José M Larrañaga-Moreira, Juan P Ochoa, Rosalía Peteiro-Debén, Esteban Martín-Álvarez, Tomás Ripoll-Vera, Perry M Elliott

JACC Heart Fail· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Education in cardiovascular genomics and genetics: time for action.
Giuseppe Limongelli, Eloisa Arbustini, Perry Mark Elliott

Eur Heart J· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Titin-related familial dilated cardiomyopathy: factors associated with disease onset.
Renee Johnson, Robert A Fletcher, Stacey Peters, Monique Ohanian, Magdalena Soka, Perry M Elliott

Eur Heart J· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of Mavacamten on Cardiac Biomarkers in Nonobstructive Hypertrophic Cardiomyopathy: Insights From the ODYSSEY-HCM Trial.
Milind Y Desai, Iacopo Olivotto, Theodore Abraham, Steven E Nissen, Pablo Garcia-Pavia, Perry M Elliott

J Am Coll Cardiol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Echocardiographic Changes With Mavacamten in Nonobstructive Hypertrophic Cardiomyopathy: Exploratory Insights From the ODYSSEY-HCM Trial.
Milind Y Desai, Yuichiro Okushi, Shada Jadam, Iacopo Olivotto, Anjali Owens, Perry M Elliott

J Am Coll Cardiol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Danicamtiv, a Selective Agonist of Cardiac Myosin, for Dilated Cardiomyopathy: A Phase 2 Open-Label Trial.
Neal K Lakdawala, Ray E Hershberger, Pablo Garcia-Pavia, Perry Mark Elliott, Jonathan Ginns

J Am Coll Cardiol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Right Ventricular Outflow Tract Diameter for Event Prediction in Arrhythmogenic Right Ventricular Cardiomyopathy: Incremental Value Over Echocardiographic Free-Wall Strain.
Thierry G Donati, Francesca Ortelli, Monika Hebeisen, Alexandros Protonotarios, Paul A S Olsen, Perry M Elliott

JACC Cardiovasc Imaging· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Childhood-onset RASopathy-associated hypertrophic cardiomyopathy, diastolic dysfunction, and arrhythmias.
Olga Dimitra Boleti, Sotirios Roussos, Emanuele Monda, Gabrielle Norrish, Ella Field, Perry Mark Elliott

Eur Heart J· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tailored therapeutics for cardiomyopathies.
Athanasios Bakalakos, Emanuele Monda, Perry Mark Elliott

Nat Rev Cardiol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Role of Myocarditis-Like Episodes and Their Treatment in Patients With Pathogenic Desmoplakin Variants.
Alessio Gasperetti, Steven A Muller, Giovanni Peretto, Babken Asatryan, Alexandros Protonotarios, Perry M Elliott

Circulation· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disease Penetrance in Genotype-Positive But Clinically Unaffected Relatives From Families With Dilated Cardiomyopathy.
Douglas E Cannie, Athanasios Bakalakos, Petros Syrris, Alexandros Protonotarios, Massimiliano Lorenzini, Perry M Elliott

JACC Heart Fail· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Redefining the Genetic Architecture of Hypertrophic Cardiomyopathy: Role of Intermediate-Effect Variants.
Soledad García Hernandez, Luis de la Higuera Romero, Adrian Fernandez, Maria Luisa Peña Peña, Nerea Mora-Ayestaran, Perry M Elliott

Circulation· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Efficacy of Aficamten in Patients With Nonobstructive Hypertrophic Cardiomyopathy: A 96-Week Analysis From FOREST-HCM.
Ahmad Masri, Mark V Sherrid, Lubna Choudhury, Pablo Garcia-Pavia, Christopher M Kramer, Perry M Elliott

J Card Fail· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hypertrophic cardiomyopathy: prevalence of disease-specific red flags.
Niccolò Maurizi, Emanuele Monda, Elena Biagini, Ella Field, Silvia Passantino, Perry M Elliott

Eur Heart J· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiomyopathy caused by mitochondrial DNA 4300A > G variant.
Anshuman Sengupta, Mohammed Majid Akhtar, Abid Mohammed Akhtar, Massimiliano Lorenzini, Thomas Slater, Perry Mark Elliott

Eur Heart J· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aficamten Treatment for Symptomatic Obstructive Hypertrophic Cardiomyopathy: 48-Week Results From FOREST-HCM.
Sara Saberi, Theodore P Abraham, Lubna Choudhury, Roberto Barriales-Villa, Perry M Elliott

JACC Heart Fail· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiac magnetic resonance markers of pre-clinical hypertrophic and dilated cardiomyopathy in genetic variant carriers.
Philip M Croon, Marion van Vugt, Cornelis P Allaart, Bram Ruijsink, Perry M Elliott

BMC Med· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Myosin inhibitors for treatment of hypertrophic cardiomyopathy.
Samuel Quill, Ahmad S Amin, Folkert W Asselbergs, Connie Bezzina, Perry M Elliott

Cochrane Database Syst Rev· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnostic Criteria and Disease Staging for Desmoplakin Cardiomyopathy.
Eric Smith, Alessio Gasperetti, Richard T Carrick, Alexandros Protonotarios, Petros Syrris, Perry M Elliott

medRxiv· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Translation of genomics into routine cardiological practice: insights from a European Society of Cardiology Cardiovascular Round Table.
Stefanie Dimmeler, Leticia Ferri, Paul Nioi, Christopher J O'Donnell, Thibaud Damy, Perry M Elliott

Eur Heart J· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NAXCARE: a clinical outcome registry for Naxos disease and related cardiocutaneous syndromes.
Adalena Tsatsopoulou, Dominic Jr Abrams, Aris Anastasakis, Loizos Antoniades, Elena Arbelo, Perry M Elliott

Hellenic J Cardiol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Naxos Disease and Related Cardio-Cutaneous Syndromes.
Alexandros Protonotarios, Angeliki Asimaki, Cristina Basso, Zafeirenia Xylouri, Emanuele Monda, Perry M Elliott

JACC Adv· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hypertrophic cardiomyopathy and atrial fibrillation: the Cardiomyopathy/Myocarditis Registry of the EURObservational Research Programme of the European Society of Cardiology.
Katarzyna Mizia-Stec, Juan R Gimeno, Philippe Charron, Perry M Elliott, Juan Pablo Kaski

Open Heart· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Electrophysiological Phenotype-Genotype Study of Sustained Monomorphic Ventricular Tachycardia in Inherited, High Arrhythmic Risk, Left Ventricular Cardiomyopathy.
Eva Cabrera-Borrego, Francisco J Bermúdez-Jiménez, Alessio Gasperetti, Harikrishna Tandri, Pablo J Sánchez-Millán, Perry M Elliott

Circ Arrhythm Electrophysiol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiac magnetic resonance markers of pre-clinical hypertrophic and dilated cardiomyopathy in genetic variant carriers.
Philip M Croon, Marion van Vugt, Cornelis P Allaart, Bram Ruijsink, Perry M Elliott

medRxiv· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis